SOURCE: Bollinger Report

February 14, 2012 09:00 ET

A Forward Look, The Year Ahead - Featured Research on Teva Pharmaceutical Industries Ltd (ADR) and Accuray Incorporated

HONG KONG--(Marketwire - Feb 14, 2012) - Today, www.BollingerReport.com introduced featured coverage of Teva Pharmaceutical Industries Ltd (ADR) (NASDAQ: TEVA) and Accuray Incorporated (NASDAQ: ARAY). Full research reports are available to readers at: www.BollingerReport.com/index.php?sm1=TEVA&sm2=ARAY.

Economic fundamentals leading into 2012 have set a generally positive pace with GDP growth likely to pick up through the coming year. However, there are several important caveats to note as the world economy continues to face headwinds and risks weigh to the downside. Positive outlooks are conditional on fiscal policy in payroll taxes and unemployment insurance benefits and upon the easing of the European debt situation. A repeat of volatility experienced in 2011 is likely in 2012, as perceptions about the strength of the U.S. economy and the euro zone will vary over time as events unfold.

Despite the current situation, our team continues to identify high momentum situations with growth potential -- there remains strong opportunity within careful discretion.

Bollinger Report screened and selected Teva Pharmaceutical Industries Ltd (ADR) for its current position within the healthcare industry. Teva Pharmaceutical Industries Limited (Teva) is a global pharmaceutical and drug company. It develops, produces and markets generic drugs in all treatment categories. The Company has a pharmaceutical business, whose principal products include Copaxone and Azilect. A copy of this report featuring Teva Pharmaceutical Industries Ltd (ADR) (NASDAQ: TEVA) is available at: www.BollingerReport.com/index.php?sm1=TEVA.

Bollinger Report is featuring Accuray Incorporated for its changing role within the healthcare industry. Accuray Incorporated has developed a robotic radiosurgery system, CyberKnife Robotic Radiosurgery System, designed to treat solid tumors anywhere in the body as an alternative to traditional surgery. Its CyberKnife system represents the radiosurgery systems, combining continuous image-guidance technology with a compact linear accelerator (linac). To download research and analysis on Accuray Incorporated (NASDAQ: ARAY) we welcome investors to visit: www.BollingerReport.com/index.php?sm2=ARAY.

About Bollinger Report
Bollinger Report has come to be known among its peers as a trusted source of information for both investors and technical traders. Our online content is continually updated, bringing fresh new researches and analyses to the investment community.

Contact Information